2019 PMDA Guideline (English Translation), “Guideline on drug interaction for drug development and appropriate provision of information”
In 2019, the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan released the official English translation of their guidance for industry.
Drug developers may also be interested in our webinar comparing the current (as of 2020) US FDA, European EMA and Japan PMDA in vitro DDI guidance documents. Approved registrants can also receive access to our related poster detailing all updates and differences discussed in the webinar.